Pereira M, Shyti R, Testa G
Stem Cell Reports. 2024; 19(6):767-795.
PMID: 38865969
PMC: 11390705.
DOI: 10.1016/j.stemcr.2024.05.004.
Petrucci A, Jones A, Kreitlow B, Buchanan G
Brain Commun. 2024; 6(2):fcae052.
PMID: 38487550
PMC: 10939444.
DOI: 10.1093/braincomms/fcae052.
Terman S, Kirkpatrick L, Kerr W, Akiyama L, Baajour W, Atilgan D
Epilepsia. 2023; 65(4):846-860.
PMID: 38135921
PMC: 11018495.
DOI: 10.1111/epi.17875.
Tchekalarova J, Todorov P, Rangelov M, Stoyanova T, Todorova N
Biomedicines. 2023; 11(11).
PMID: 38001914
PMC: 10669120.
DOI: 10.3390/biomedicines11112912.
Kagan B, Gyngell C, Lysaght T, Cole V, Sawai T, Savulescu J
Biotechnol Adv. 2023; 68:108233.
PMID: 37558186
PMC: 7615149.
DOI: 10.1016/j.biotechadv.2023.108233.
Development of Antiepileptic Drugs throughout History: From Serendipity to Artificial Intelligence.
Corrales-Hernandez M, Villarroel-Hagemann S, Mendoza-Rodelo I, Palacios-Sanchez L, Gaviria-Carrillo M, Buitrago-Ricaurte N
Biomedicines. 2023; 11(6).
PMID: 37371727
PMC: 10295412.
DOI: 10.3390/biomedicines11061632.
Zebrafish as an Innovative Tool for Epilepsy Modeling: State of the Art and Potential Future Directions.
dAmora M, Galgani A, Marchese M, Tantussi F, Faraguna U, De Angelis F
Int J Mol Sci. 2023; 24(9).
PMID: 37175408
PMC: 10177843.
DOI: 10.3390/ijms24097702.
Translational Considerations in the Development of Intranasal Treatments for Epilepsy.
Prentice R, Rizwan S
Pharmaceutics. 2023; 15(1).
PMID: 36678862
PMC: 9865314.
DOI: 10.3390/pharmaceutics15010233.
Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.
Del Pozo A, Barker-Haliski M
Exp Neurol. 2022; 360:114288.
PMID: 36471511
PMC: 9789191.
DOI: 10.1016/j.expneurol.2022.114288.
Anticonvulsant Activity of -Anethole in Mice.
da Guedes E, Ribeiro L, Carneiro C, Santos A, Monteiro A, Andrade H
Biomed Res Int. 2022; 2022:9902905.
PMID: 35607305
PMC: 9124115.
DOI: 10.1155/2022/9902905.
A complex systems view on the current hypotheses of epilepsy pharmacoresistance.
Servilha-Menezes G, Garcia-Cairasco N
Epilepsia Open. 2022; 7 Suppl 1:S8-S22.
PMID: 35253410
PMC: 9340300.
DOI: 10.1002/epi4.12588.
Rational Small Molecule Treatment for Genetic Epilepsies.
Goldberg E
Neurotherapeutics. 2021; 18(3):1490-1499.
PMID: 34431030
PMC: 8609069.
DOI: 10.1007/s13311-021-01110-w.
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
Loscher W, Klein P
CNS Drugs. 2021; 35(9):935-963.
PMID: 34145528
PMC: 8408078.
DOI: 10.1007/s40263-021-00827-8.
Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies.
Garcia-Rosa S, Brenha B, da Rocha V, Goulart E, Araujo B
Curr Neuropharmacol. 2020; 19(6):813-831.
PMID: 32933463
PMC: 8686309.
DOI: 10.2174/1570159X18666200915151909.
Antiseizure drug efficacy and tolerability in established and novel drug discovery seizure models in outbred vs inbred mice.
Koneval Z, Knox K, Memon A, Zierath D, White H, Barker-Haliski M
Epilepsia. 2020; 61(9):2022-2034.
PMID: 32757210
PMC: 7722177.
DOI: 10.1111/epi.16624.
The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy.
Wilcox K, West P, Metcalf C
Neuropharmacology. 2019; 166:107811.
PMID: 31790717
PMC: 7054975.
DOI: 10.1016/j.neuropharm.2019.107811.
Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening.
Barker-Haliski M, White H
Neuropharmacology. 2019; 167:107750.
PMID: 31469995
PMC: 7470169.
DOI: 10.1016/j.neuropharm.2019.107750.
Design, synthesis and biological evaluation of N-substituted α-hydroxyimides and 1,2,3-oxathiazolidine-4-one-2,2-dioxides with anticonvulsant activity.
Sabatier L, Palestro P, Enrique A, Pastore V, Sbaraglini M, Martin P
J Enzyme Inhib Med Chem. 2019; 34(1):1465-1473.
PMID: 31411081
PMC: 6713207.
DOI: 10.1080/14756366.2019.1651722.
The 4-Aminopyridine Model of Acute Seizures Elucidates Efficacy of New Antiepileptic Drugs.
Heuzeroth H, Wawra M, Fidzinski P, Dag R, Holtkamp M
Front Neurosci. 2019; 13:677.
PMID: 31316344
PMC: 6610309.
DOI: 10.3389/fnins.2019.00677.
Brief history of anti-seizure drug development.
Rho J, White H
Epilepsia Open. 2018; 3(Suppl Suppl 2):114-119.
PMID: 30564769
PMC: 6293064.
DOI: 10.1002/epi4.12268.
